A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services
Open Access
- 7 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12, 669871
- https://doi.org/10.3389/fendo.2021.669871
Abstract
Background/Aims: There is no universal consensus on the practical implementation and evaluation of the Amsterdam Declaration on Graves Orbitopathy in a Multidisciplinary Thyroid Eye Disease (MDTED) pathway. Recent recommendations from the UK TEAMeD-5 and BOPSS initiative highlight the importance of prevention, screening, and prompt referral of patients with moderate to severe and sight-threatening thyroid eye disease to multidisciplinary (MDTED) clinics and recommends annual auditing. We propose a practical service evaluation model with Key Performance Indicators (KPI) that are achievable and could be implemented across most TED pathways. Material and Methods: We conducted a service evaluation from an integrated TED pathway in London with three MDTED clinics. Data was collected retrospectively from consecutive TED patients included: 1) Patient demographics, 2) Referral to first appointment time, 3) Documented smoking cessation and selenium supplementation advice, 4) Presenting disease activity and severity, 5) Investigations and treatments, including radio-iodine, 6) Time from decision to treatment initiation, 7) Initial and subsequent thyroid status. Results: The median age was 49.0 yrs, 77.5% (183/236) were female and 49.5% (101/204) Afro-Caribbean or Asian. At their first clinic attendance, 47.6% (110/231) were biochemically euthyroid and 76.7% (79/103) at discharge. All 23.1% (52/225) current smokers received smoking cessation advice and 64.8% (153/236) received selenium supplementation advice. Intravenous methylprednisolone was given to 33.9% (80/236) patients and 12.7% (30/236) received second-line immunosuppression. All 7.2% (17/236) patients with sight-threatening disease received treatment within two weeks of diagnosis. Conclusions: This study forms a waymark for other units using TEAMeD-5 and BOPSS audit criteria. Dedicated electronic patient records with ongoing data capture, including quality of life assessments, and diagnostic coding would significantly aid future auditing, improve patient care, and facilitate a national audit of TED management. A future survey when the TED standards have become embedded would be instructive to see whether this has improved TED care.Funding Information
- Imperial College London
This publication has 22 references indexed in Scilit:
- The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyEuropean Thyroid Journal, 2016
- Thyroid eye disease audit - the Wolverhampton experienceEndocrine Abstracts, 2015
- PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012British Journal of Ophthalmology, 2015
- What Are the Psychosocial Outcomes of Treatment for Thyroid Eye Disease? A Systematic ReviewThyroid®, 2014
- Management of patients in a combined thyroid eye clinic in secondary careInternational Ophthalmology, 2013
- Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single CenterJournal of Clinical Endocrinology & Metabolism, 2013
- Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid diseaseBest Practice & Research Clinical Endocrinology & Metabolism, 2012
- Quality of life in thyroid eye disease: impact of quality of careActa Endocrinologica, 2011
- Radioiodine therapy (RAI) for Graves’ disease (GD) and the effect on ophthalmopathy: a systematic review*Clinical Endocrinology, 2008
- Is enough attention being given to the adverse effects of corticosteroid therapy?Journal of Clinical Pharmacy & Therapeutics, 2000